Albulym Obaid M, Zhu Danqing, Reddel Stephen, Kennerson Marina, Nicholson Garth
Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord, NSW 2139, Australia ; Sydney Medical School, University of Sydney, Sydney, NSW 2008, Australia.
Molecular Medicine Laboratory, Concord Hospital, Concord, NSW 2139, Australia.
J Neurodegener Dis. 2013;2013:495873. doi: 10.1155/2013/495873. Epub 2012 Nov 28.
Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous group of disorders affecting both motor and sensory neurons in the peripheral nervous system. Mutations in the MFN2 gene cause an axonal form of CMT, CMT2A. The V705I variant in MFN2 has been previously reported as a disease-causing mutation in families with CMT2. We identified an affected index patient from an Australian multigenerational family with the V705I variant. Segregation analysis showed that the V705I variant did not segregate with the disease phenotype and was present in control individuals with an allele frequency of 4.4%. We, therefore, propose that the V705I variant is a polymorphism and not a disease-causing mutation as previously reported.
夏科-马里-图思(CMT)病是一组临床和遗传异质性疾病,影响周围神经系统的运动和感觉神经元。MFN2基因突变会导致CMT的轴索性形式,即CMT2A。此前已有报道称,MFN2基因中的V705I变异是CMT2家族中的致病突变。我们从一个澳大利亚多代家族中鉴定出一名携带V705I变异的患病索引患者。分离分析表明,V705I变异与疾病表型不连锁,且在对照个体中存在,等位基因频率为4.4%。因此,我们认为V705I变异是一种多态性,而非如先前报道的致病突变。